Cargando…
Nanomedicine in Oncocardiology: Contribution and Perspectives of Preclinical Studies
Cancer and cardiovascular diseases are the leading causes of death and morbidity worldwide. Strikingly, cardiovascular disorders are more common and more severe in cancer patients than in the general population, increasing incidence rates. In this context, it is vital to consider the anticancer effi...
Autores principales: | Borges, Gabriel Silva Marques, Lages, Eduardo Burgarelli, Sicard, Pierre, Ferreira, Lucas Antônio Miranda, Richard, Sylvain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277942/ https://www.ncbi.nlm.nih.gov/pubmed/34277738 http://dx.doi.org/10.3389/fcvm.2021.690533 |
Ejemplares similares
-
Establishing an oncocardiology service
por: Lehmann, L. H., et al.
Publicado: (2020) -
Oncocardiology: new challenges, new opportunities
por: Michel, Lars, et al.
Publicado: (2020) -
Is Transient Takotsubo Syndrome Associated With Cancer? Why, and With What Implications for Oncocardiology?
por: Angelini, Paolo, et al.
Publicado: (2019) -
Anti-inflammatory Nanomedicine for Cardiovascular Disease
por: Katsuki, Shunsuke, et al.
Publicado: (2017) -
Experimental Myocardial Infarction Elicits Time-Dependent Patterns of Vascular Hypoxia in Peripheral Organs and in the Brain
por: David, Hélène, et al.
Publicado: (2021)